Your browser doesn't support javascript.
loading
Revised Australian national guidelines for colorectal cancer screening: family history.
Jenkins, Mark A; Ait Ouakrim, Driss; Boussioutas, Alex; Hopper, John L; Ee, Hooi C; Emery, Jon D; Macrae, Finlay A; Chetcuti, Albert; Wuellner, Laura; St John, D James B.
Afiliação
  • Jenkins MA; University of Melbourne, Melbourne, VIC m.jenkins@unimelb.edu.au.
  • Ait Ouakrim D; University of Melbourne, Melbourne, VIC.
  • Boussioutas A; Royal Melbourne Hospital, Melbourne, VIC.
  • Hopper JL; University of Melbourne, Melbourne, VIC.
  • Ee HC; Sir Charles Gardiner Hospital, Perth, WA.
  • Emery JD; University of Melbourne, Melbourne, VIC.
  • Macrae FA; Royal Melbourne Hospital, Melbourne, VIC.
  • Chetcuti A; Cancer Council Australia, Sydney, NSW.
  • Wuellner L; Agency for Clinical Innovation, Sydney, NSW.
  • St John DJB; Cancer Council Victoria, Melbourne, VIC.
Med J Aust ; 209(10): 455-460, 2018 11 19.
Article em En | MEDLINE | ID: mdl-30359558
ABSTRACT

INTRODUCTION:

Screening is an effective means for colorectal cancer prevention and early detection. Family history is strongly associated with colorectal cancer risk. We describe the rationale, evidence and recommendations for colorectal cancer screening by family history for people without a genetic syndrome, as reported in the 2017 revised Australian guidelines. Main

recommendations:

Based on 10-year risks of colorectal cancer, people at near average risk due to no or weak family history (category 1) are recommended screening by immunochemical faecal occult blood test (iFOBT) every 2 years from age 50 to 74 years. Individuals with moderate risk due to their family history (category 2) are recommended biennial iFOBT from age 40 to 49 years, then colonoscopy every 5 years from age 50 to 74 years. People with a high risk due to their family history (category 3) are recommended biennial iFOBT from age 35 to 44 years, then colonoscopy every 5 years from age 45 to 74 years. Changes in management as a result of the guidelines By 2019, the National Bowel Cancer Screening Program will offer all Australians free biennial iFOBT screening from age 50 to 74 years, consistent with the recommendations in these guidelines for category 1. Compared with the 2005 guidelines, there are some minor changes in the family history inclusion criteria for categories 1 and 2; the genetic syndromes have been removed from category 3 and, as a consequence, colonoscopy screening is now every 5 years; and for categories 2 and 3, screening begins with iFOBT for people aged 40 and 35 years, respectively, before transitioning to colonoscopy after 10 years.
Assuntos
Palavras-chave
Buscar no Google
Coleções: 01-internacional Temas: Atencao_primaria_forma_integrada Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Programas de Rastreamento / Guias de Prática Clínica como Assunto / Detecção Precoce de Câncer / Anamnese Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Med J Aust Ano de publicação: 2018 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Temas: Atencao_primaria_forma_integrada Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Programas de Rastreamento / Guias de Prática Clínica como Assunto / Detecção Precoce de Câncer / Anamnese Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Med J Aust Ano de publicação: 2018 Tipo de documento: Article